We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Launches Generic Drug Cluster to Increase Alignment Among International Regulators
FDA Launches Generic Drug Cluster to Increase Alignment Among International Regulators
The FDA has launched the Generic Drug Cluster, calling it the first forum of its kind focused on increasing scientific alignment among regulatory agencies in countries that focus on generic drug development.